FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Breakthrough Status for Heart Failure Device

FDA grants Restore Medical a breakthrough device designation for its ContraBand device and its use in treating certain heart failures with reduced eje...

latest-news-card-1
Human Drugs

Phathom Pharma Heartburn Drug Expanded Use

FDA approves a Phathom Pharmaceuticals NDA for Voquezna (vonoprazan) 10 mg tablets for relieving heartburn associated with non-erosive gastroesophagea...

latest-news-card-1
Medical Devices

2 More Warning Letters for Chinese Plastic Syringes

FDA says two additional Warning Letters have been issued to Chinese medical device firms as part of its evaluation of defective plastic enteral syring...

latest-news-card-1
Human Drugs

Human Radiolabeled Mass Balance Study Guide

FDA publishes a guidance with recommendations on clinical pharmacology considerations for conducting human radiolabeled mass balance studies of invest...

latest-news-card-1
Federal Register

Guide on Blood Pressure Donor Eligibility

Federal Register notice: FDA makes available a final guidance entitled Blood Pressure and Pulse Donor Eligibility Requirements: Compliance Policy.

Medical Devices

Philips Updates Ventilator Instructions

FDA says a 4/1 Philips Respironics recall revising the use instructions for its OmniLab Advanced+ ventilator is Class 1.

latest-news-card-1
Medical Devices

Subtle Medical Imaging Software Cleared

FDA clears a Subtle Medical 510(k) for its SubtleSYNTH, which uses deep learning to generate synthetic Short Tau Inversion Recovery images from alread...

latest-news-card-1
Medical Devices

Baxter Recalls Volara System Ventilator Adapter

Baxter International recalls (Class 1) certain lots of the Volara system single-patient use circuit and blue ventilator adapter assembly due to report...

latest-news-card-1
Federal Register

Comments Extended for Guide on Platform Technology

Federal Register notice: FDA extends the comment period on its draft guidance entitled Platform Technology Designation Program for Drug Development....

latest-news-card-1
Human Drugs

FDA Opening Rare Disease Innovation Hub

CDER director Patrizia Cavazzoni and CBER director Peter Marks say they are co-leading a new FDA Rare Disease Innovation Hub.